Literature DB >> 34283310

Proline dehydrogenase in cancer: apoptosis, autophagy, nutrient dependency and cancer therapy.

Yating Liu1,2,3, Chao Mao2,3, Shuang Liu4, Desheng Xiao5,6, Ying Shi7,8, Yongguang Tao9,10,11.   

Abstract

L-proline catabolism is emerging as a key pathway that is critical to cellular metabolism, growth, survival, and death. Proline dehydrogenase (PRODH) enzyme, which catalyzes the first step of proline catabolism, has diverse functional roles in regulating many pathophysiological processes, including apoptosis, autophagy, cell senescence, and cancer metastasis. Notably, accumulated evidence demonstrated that PRODH plays complex role in many types of cancers. In this review, we briefly introduce the function of PRODH, then its expression in different types of cancer. We next discuss the regulation of PRODH in cancer, the downstream pathways of PRODH and the therapies that are under investigation. Finally, we propose novel insights for future perspectives on the modulation of PRODH.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; Autophagy; Cancer; L-proline; PRODH; p53

Mesh:

Substances:

Year:  2021        PMID: 34283310     DOI: 10.1007/s00726-021-03032-5

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  99 in total

1.  Endogenous siRNAs derived from a pair of natural cis-antisense transcripts regulate salt tolerance in Arabidopsis.

Authors:  Omar Borsani; Jianhua Zhu; Paul E Verslues; Ramanjulu Sunkar; Jian-Kang Zhu
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 2.  Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.

Authors:  Sameer Agnihotri; Gelareh Zadeh
Journal:  Neuro Oncol       Date:  2015-07-14       Impact factor: 12.300

Review 3.  Metabolism of proline and of hydroxyproline.

Authors:  E Adams
Journal:  Int Rev Connect Tissue Res       Date:  1970

Review 4.  Glutamine as an Essential Amino Acid for KRas-Driven Cancer Cells.

Authors:  Elyssa Bernfeld; David A Foster
Journal:  Trends Endocrinol Metab       Date:  2019-04-27       Impact factor: 12.015

Review 5.  Targeting Autophagy in Cancer: Recent Advances and Future Directions.

Authors:  Ravi K Amaravadi; Alec C Kimmelman; Jayanta Debnath
Journal:  Cancer Discov       Date:  2019-08-21       Impact factor: 39.397

6.  Inhibition of Glutamine Utilization Synergizes with Immune Checkpoint Inhibitor to Promote Antitumor Immunity.

Authors:  Jun-Kyu Byun; Mihyang Park; Seunghyeong Lee; Jae Won Yun; Jaebon Lee; Jae Sun Kim; Sung Jin Cho; Hui-Jeon Jeon; In-Kyu Lee; Yeon-Kyung Choi; Keun-Gyu Park
Journal:  Mol Cell       Date:  2020-11-06       Impact factor: 17.970

Review 7.  PPARγ signaling and metabolism: the good, the bad and the future.

Authors:  Maryam Ahmadian; Jae Myoung Suh; Nasun Hah; Christopher Liddle; Annette R Atkins; Michael Downes; Ronald M Evans
Journal:  Nat Med       Date:  2013-05-07       Impact factor: 53.440

Review 8.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.

Authors:  Gloria Bertoli; Claudia Cava; Isabella Castiglioni
Journal:  Theranostics       Date:  2015-07-13       Impact factor: 11.556

9.  Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line.

Authors:  Pamela Cappelletti; Elena Tallarita; Valentina Rabattoni; Paola Campomenosi; Silvia Sacchi; Loredano Pollegioni
Journal:  PLoS One       Date:  2018-04-25       Impact factor: 3.240

Review 10.  The Janus-like role of proline metabolism in cancer.

Authors:  Lynsey Burke; Inna Guterman; Raquel Palacios Gallego; Robert G Britton; Daniel Burschowsky; Cristina Tufarelli; Alessandro Rufini
Journal:  Cell Death Discov       Date:  2020-10-14
View more
  4 in total

Review 1.  Proline Metabolism in Malignant Gliomas: A Systematic Literature Review.

Authors:  Magdalena M Sawicka; Karol Sawicki; Tomasz Łysoń; Barbara Polityńska; Wojciech Miltyk
Journal:  Cancers (Basel)       Date:  2022-04-17       Impact factor: 6.575

2.  MDN1 Mutation Is Associated With High Tumor Mutation Burden and Unfavorable Prognosis in Breast Cancer.

Authors:  Shuai Hao; Miao Huang; Xiaofan Xu; Xulin Wang; Liqun Huo; Lu Wang; Jun Gu
Journal:  Front Genet       Date:  2022-03-21       Impact factor: 4.599

3.  Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.

Authors:  Jinjiong Hong; Qun Li; Xiaofeng Wang; Jie Li; Wenquan Ding; Haoliang Hu; Lingfeng He
Journal:  J Clin Lab Anal       Date:  2022-05-16       Impact factor: 3.124

Review 4.  Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective.

Authors:  Ajay Kumar Pal; Prateek Sharma; Alishan Zia; Deepali Siwan; Dipali Nandave; Mukesh Nandave; Rupesh K Gautam
Journal:  Pathophysiology       Date:  2022-05-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.